Jason Lettmann Insider Trading $RARX Ra Pharmaceuticals, Inc.

FREE EMAIL WATCHDOG

Get free email notifications about insider trading for Jason Lettmann.

Your email is safe with us.
The service is free and you can unsubscribe at any time.

General | Insider Transactions | Monthly Overview

Get the latest insider transactions of Jason Lettmann. Jason Lettmann is Director in Ra Pharmaceuticals, Inc. ($RARX) and Director in ALX ONCOLOGY HOLDINGS INC ($ALXO).

Jason Lettmann in Ra Pharmaceuticals, Inc.

Trading Symbol: RARX
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Jason Lettmann: Director
Holdings: 80,161 shares
Current Value: $1,456,525
Latest Transaction: Jun 22 2017
$RARX Market Capitalization: $405.38M
$RARX Previous Close: $18.17

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD

Latest Insider Trading Transactions of Jason Lettmann in Ra Pharmaceuticals, Inc.

	1 Week	2 Weeks	1 Month	3 Months	6 Months	1 Year	2 Years
No. of Purchases	0	0	0	0	0	0	0
Value of Purchases ($)	0	0	0	0	0	0	0
No. of Sales	0	0	0	0	0	0	0
Value of Sales ($)	0	0	0	0	0	0	0

Sentiment: All, ALXO, RARX

Page: 1

Date	Ticker	Company	Owner	Relationship	Transaction	Code	Cost ($)	Shares	Transaction Value ($)	Total Shares	% Holdings
Jun 22 2017	RARX	Ra Pharmaceuticals ...	Lettmann Jason	Director	Option Exercise	A	22.37	15,000	335,550	15,000
Oct 31 2016	RARX	Ra Pharmaceuticals ...	Lettmann Jason	Director	Option Exercise	C	0.00	481,503	0	0
Oct 31 2016	RARX	Ra Pharmaceuticals ...	Lettmann Jason	Director	Option Exercise	C	0.00	3,533,875	0	0
Oct 31 2016	RARX	Ra Pharmaceuticals ...	Lettmann Jason	Director	Option Exercise	C	0.00	517,617	0	0
Oct 31 2016	RARX	Ra Pharmaceuticals ...	Lettmann Jason	Director	Option Exercise	C	0.00	3,798,914	0	0
Oct 31 2016	RARX	Ra Pharmaceuticals ...	Lettmann Jason	Director	Option Exercise	C	0.00	3,408,439	0	0
Oct 31 2016	RARX	Ra Pharmaceuticals ...	Lettmann Jason	Director	Option Exercise	C	0.00	3,664,071	0	0
Oct 31 2016	RARX	Ra Pharmaceuticals ...	Lettmann Jason	Director	Option Exercise	C	0.00	9,744,916	0	0
Oct 31 2016	RARX	Ra Pharmaceuticals ...	Lettmann Jason	Director	Option Exercise	X	0.07	63,019	4,411	0
Oct 31 2016	RARX	Ra Pharmaceuticals ...	Lettmann Jason	Director	Buy	P	13.00	15,633	203,229	4,066,503	4.1 M to 4.1 M (+0.39 %)
Oct 31 2016	RARX	Ra Pharmaceuticals ...	Lettmann Jason	Director	Buy	P	13.00	114,752	1,491,776	4,050,870	3.9 M to 4.1 M (+2.92 %)
Oct 31 2016	RARX	Ra Pharmaceuticals ...	Lettmann Jason	Director	Buy	P	13.00	263,538	3,425,994	3,936,118	3.7 M to 3.9 M (+7.18 %)
Oct 31 2016	RARX	Ra Pharmaceuticals ...	Lettmann Jason	Director	Buy	C	0.00	68,786	0	3,672,580	3.6 M to 3.7 M (+1.91 %)
Oct 31 2016	RARX	Ra Pharmaceuticals ...	Lettmann Jason	Director	Buy	C	0.00	504,839	0	3,603,794	3.1 M to 3.6 M (+16.29 %)
Oct 31 2016	RARX	Ra Pharmaceuticals ...	Lettmann Jason	Director	Buy	C	0.00	73,945	0	3,098,955	3 M to 3.1 M (+2.44 %)
Oct 31 2016	RARX	Ra Pharmaceuticals ...	Lettmann Jason	Director	Buy	C	0.00	542,702	0	3,025,010	2.5 M to 3 M (+21.86 %)
Oct 31 2016	RARX	Ra Pharmaceuticals ...	Lettmann Jason	Director	Buy	C	0.00	486,919	0	2,482,308	2 M to 2.5 M (+24.40 %)
Oct 31 2016	RARX	Ra Pharmaceuticals ...	Lettmann Jason	Director	Buy	C	0.00	523,438	0	1,995,389	1.5 M to 2 M (+35.56 %)
Oct 31 2016	RARX	Ra Pharmaceuticals ...	Lettmann Jason	Director	Buy	C	0.00	1,392,130	0	1,471,951	79.8 K to 1.5 M (+1,744.06 %)
Oct 31 2016	RARX	Ra Pharmaceuticals ...	Lettmann Jason	Director	Sell	S	13.00	340	4,420	79,821	80.2 K to 79.8 K (-0.42 %)
Oct 31 2016	RARX	Ra Pharmaceuticals ...	Lettmann Jason	Director	Buy	X	0.07	63,019	4,411	80,161	17.1 K to 80.2 K (+367.63 %)

Page: 1